Molecular Aspects of Anticancer Drug/DNA Interactions: v. 2 (Topics in Molecular & Structural Biology)

Stephen Neidle (Editor), Michael J. Waring (Editor)

ISBN 10: 0333602382 / ISBN 13: 9780333602386

Verlag: Palgrave Macmillan, UK, 1994

Beschreibung

0333602382. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed, corner bump. 367 pages, index, illustrated with charts, tables and colour plates. Sections include: DNA topomerases; Pharmacology of the anthrapyrazole antitumour agents; Calicheamicin; Intercalator-groove binder hybrid molecules; Bleomycins; Drug-nucleic acid binding modes; Acridine-based anticancer drugs; The Mitomycins: natural cross-linkers of DNA. Contents clean, tight and bright.

Bestandsnummer des Verkäufers 021197

Bibliografische Details

• Titel: Molecular Aspects of Anticancer Drug/DNA Interactions: v. 2 (Topics in Molecular & Structural Biology)
• Verlag: Palgrave Macmillan, UK
• Erscheinungsjahr: 1994
• Sprache: Englisch
• ISBN-10: 0333602382
• ISBN-13: 9780333602386
• Einband: Hardcover
• Zustand: Good
• Zustand des Schutzumschlags: No Jacket
• Buchtyp: Book
• Verkäuferkataloge:
  • Medical Research

Über diesen Titel

Inhaltsangabe

This series provides researchers in the biological and medical sciences with timely reviews of selected areas in the molecular biology. Each volume is edited by an internationally recognised authority who selects authors and topics to provide a survey of current growth points in a specific field. "Molecular Aspects of Anticancer Drug - DNA Interactions" aims to be a definitive work in the cancer chemotherapy area replacing the editors' previous book on anti-cancer drug design which though still widely quoted as the "standard work", in the field has now become rather out of date. Such is the wealth of important new material generated by prominent workers in this area, that the publishers have found it necessary to split the text text into two volumes. Volume one was published several months ago.